The government has ordered 7,700 doses of sotrovimab. But until further evidence shows it’s effective, the guidelines say it should only be given to patients as part of a human clinical trial.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Antibody
Menampilkan semua artikel
The virus is evolving and new strains are more transmissible. Will the vaccines work against these new variants? How can researchers stay ahead of the virus’s evolution?
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
The president and first lady Melania Trump have both tested positive for the coronavirus. Here’s what the physicians and scientists know about the best treatments for the disease it causes.
Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
If antibody levels drop dramatically after an infection, what does that mean for immunity? An expert explains how B and T cells contribute to immunity and why antibodies don’t tell the full story.
Some people’s blood can mount an immune response against SARS-CoV-2, even if those blood samples were taken from before the COVID-19 pandemic started.
If immunity is short-lived, we will be in an ongoing cycle of endless reinfection.
If you have had COVID-19 already, are you protected from another bout of the illness? And is the presence of antibodies in your blood a guarantee of immunity?
The antibody can be used to diagnose Alzheimer’s disease.
Immunity passports have been touted as a way to reopen the economy. But there are serious concerns they’ll create an incentive to intentionally contract the coronavirus.
Nearly two million antibody tests imported into Australia can’t be used to diagnose COVID-19. But it’s difficult to make an antibody test that is specific and sensitive enough.
A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.
Cellphone data can show who coronavirus patients interacted with, which can help isolate infected people before they feel ill. But how digital contact tracing is implemented matters.
University of Pittsburgh researchers are developing a vaccine patch for COVID-19 that is as easy to apply as a Band-Aid.
Kontributor teratas
-
Professor of Medicine, University of Virginia
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Program Director, Infectious Diseases and Immunology, Menzies Health Institute, Griffith University
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Senior Lecturer, University of Sydney
-
Professor of Law and Faculty Director, Technology, Law & Security Program, American University
-
Professor of Dermatology, University of Pittsburgh
-
Professor of Immunology, Tufts University
-
Assistant Professor, University at Buffalo
-
Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh
-
Professor of Biophysics, University of Cambridge
-
Pharmacist and PhD Candidate, University of Sydney
-
Postdoctoral Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Assistant Professor of Medicine, University of Virginia
